This newsletter contains the following CLL Global Alliance Meeting Highlights, which I'm sure will be welcome news to us all!
"On January 15-16, 2016, CLL Global hosted our semi-annual Alliance meeting in Houston, Texas. The Alliance meetings provide a unique opportunity for the unhindered exchange of ideas and the development of collaborations among CLL experts from around the world. The focus of the January meeting was "How can our research accelerate the cure of CLL?". Included in the meeting were sessions on immunology, genetics, pathways and signaling, drug development, the complexity of the "stromal jungle", and how these topics relate to CLL. Presentations highlighted several areas of relevance to CLL, including:
1) the role of viruses in cancer
2) the recognition of the importance of what was once called "junk" DNA in regulating normal and abnormal cell function
3) the recognition of the ever-increasing complexity of the immune system, how it prevents cancer, and how cancer evades it
4) the development of novel targeted therapies that are revolutionizing treatment options for high-risk and relapsed/refractory CLL patients, and
5) other cancers, including melanoma and non-melanoma skin cancers that are prevalent in CLL patients, as well as mutations that are associated with disease clusters.
The meeting ended with an exciting discussion of the development of vaccines against cancer that have the potential to transform treatment options in much the same way monoclonal antiboides have since the advent of rituximab."
Interesting articles from previous newsletters are available from the CLL Global Tidbits archive page:
Those interested in receiving this newsletter can join the mailing list by clicking on Join our Mailing List! at the bottom of the above page.